Extra-Hepatic Isozymes from the CYP1 and CYP2 Families as Potential Chemotherapeutic Targets

E-ISSN： 1873-4294|13|12|1441-1453

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.13, Iss.12, 2013-06, pp. : 1441-1453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characterization and expression of extrahepatic CYP2S1

By Deb Subrata Bandiera Stelvio M

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 4, 2009-04 ,pp. : 367-380

Informa Healthcare

Access to resources Recommend Favorite

CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global Pharmacogenetics

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 1, 2012-03 ,pp. : 43-53

Bentham Science Publishers

Access to resources Recommend Favorite

Human Cytochromes P450 Associated with the Phase 1 Metabolism of Drugs and other Xenobiotics: A Compilation of Substrates and Inhibitors of the CYP1, CYP2 and CYP3 Families

Current Medicinal Chemistry, Vol. 10, Iss. 19, 2003-10 ,pp. : 1955-1972

Bentham Science Publishers

Access to resources Recommend Favorite

Alcoholic Liver Disease: from CYP2E1 to CYP2A5

Current Molecular Pharmacology, Vol. 10, Iss. 3, 2017-05 ,pp. : 172-178

Bentham Science Publishers

Access to resources Recommend Favorite

Extrahepatic Metabolism by CYP2E1 in PBPK Modeling of Lipophilic Volatile Organic Chemicals: Impacts on Metabolic Parameter Estimation and Prediction of Dose Metrics

By Yoon Miyoung Madden Michael C. Barton Hugh A.

Journal of Toxicology and Environmental Health, Vol. 70, Iss. 18, 2007-01 ,pp. : 1527-1541

Taylor & Francis Ltd

Access to resources Recommend Favorite